Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

People who inject drugs (PWID) are at exceptionally high risk of contracting HIV and viral hepatitis. The European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses gaps in the prevention of HIV and other co-infections in the European Union. This session will focus on harm reduction services in Europe for PWID, presenting new findings and good practices from this major European project. Good practices include e.g. tailored low threshold services for women who use drugs, harm reduction for prisoners, and mobile unit outreach work. Barriers of access to prevention and treatment services, as well as integration of care for PWID will be discussed in the session. Session objectives are to disseminate information on findings of the HA-REACT Joint Action and to provoke discussion with other Health Programme activities on challenges and good practices of prevention of HIV and co-infections and integration of care for PWID.

14:45
MOSA3801
Opening of the Satellite
Mika Salminen, National Institute for Health and Welfare, Finland
Jean Luc Sion, European Commission,, Luxembourg
14:55
MOSA3802
EU Policy framework, presenting the Staff Working Document 2018
Jean Luc Sion, European Commission,, Luxembourg
Slides
15:05
MOSA3803
HIV/HCV testing within low-threshold services for women who use drugs – barriers and recommendations
Alexandra Gurinova, Deutsche AIDS-Hilfe, Germany
Slides
15:15
MOSA3804
Harm reduction services in prisons: gaps, challenges and good practice examples
Heino Stöver, Frankfurt University of Applied Sciences (ISFF), Germany
Slides
15:25
MOSA3805
Harm reduction services in Europe, Mobile unit service for PWID in Latvia
Luis Sordo Del Castillo, Biomedical Research Networking Centre (CIBER/ISCIII), Spain
Slides
15:35
MOSA3807
Guidance on prevention and control of blood-borne viruses in prison settings
Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
Slides
15:45
MOSA3806
Access barriers and good practices to promote prevention and treatment services for PWID
Jeffrey Lazarus, Barcelona Institute for Global Health, Spain
Slides
15:55
MOSA3808
Round table discussion: What are the challenges for preventing HIV and co-infections among PWID, what have we learnt from HA-REACT and other EU actions, and how can we respond to these challenges? What does integration of services for PWID mean?Panellists from:
16:45
MOSA3809
Joint Action on integrating prevention, testing and linkage to care strategies acros HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE)
Dorthe Raben, CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Denmark
17:05
MOSA3810
Early diagnosis and treatment of viral hepatitis (HepCare Europe)
17:25
MOSA3811
Early detection and integrated management of tuberculosis in Europe (E-DETECT TB)
Gerard de Vries, KNCV Tuberculosis Foundation, Netherlands
17:45
MOSA3812
European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)
Aljona Kurbatova, National Institute for Health Development, Estonia
18:05
MOSA3813
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
Slides